Webinar Description
Heart failure (HF) and arrhythmias are no longer separate conversations. Increasingly, clinicians are asking a more important question: is the arrhythmia causing HF or vice versa?
In this webinar, John Rogers, MD, MS, FACC, FHRS, will explore how long-term cardiac monitoring is reshaping risk assessment, therapy guidance, and clinical decision-making across a range of patient populations. The discussion will examine how monitoring has evolved beyond traditional arrhythmia detection to support earlier intervention, improved patient selection and more actionable insights, including emerging data in HF populations with mid-range ejection fraction and cardiomyopathy.
Attendees will gain practical perspectives on selecting monitoring strategies for different patient profiles, the value of long-term monitoring and high-quality alerts, bridging the gap between electrophysiology (EP) and HF care, and how diagnostic innovation is influencing therapeutic decisions. Designed for cardiology, EP and HF leaders, as well as cardiovascular administrators, this session connects emerging evidence with real-world implementation considerations.
To obtain your CME credits, a post-webinar exam and evaluation will be required through the Academy.
Speakers
John Rogers, MD, MS, FACC, FHRS, Vice President Department of Medicine Director, Cardiac Pacing and Tachyarrhythmia Device Therapy Scripps Clinic
Accreditation and Designation Statements and Disclosure Report
This activity has been planned and implemented in accordance with the accreditation requirements and
policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint
providership of International Institute for Continuing Medical Education and MedAxiom. International
Institute for Continuing Medical Education is accredited by the ACCME to provide continuing medical
education for physicians.
International Institute for Continuing Medical Education designates the live format for this educational
activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Live activity date: July 14, 2026
International Institute for Continuing Medical Education designates the enduring format for this
educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only
claim credit commensurate with the extent of their participation in the activity.
Enduring activity dates: July 14, 2026 – July 14, 2029
Other Healthcare Professionals:
Nurse Practitioners and Registered Nurses
The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1
CreditsTM from organizations accredited by the ACCME. Visit the ANCC’s website for more
information.
Pharmacists
Different state boards of pharmacy have different requirements for continuing education. Some
accept CME credit, while others accept only ACPE-approved CPE (continuing pharmacy
education) credit. Please refer to your state board of pharmacy to find out if CME is accepted.
Please note that all final decisions about credit hour acceptance will be made by the licensing
organization to which the credit hours are submitted.
Physician Assistants
NCCPA accepts AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a
recognized state medical society.
Financial Disclosures
The following planners, faculty, reviewers or staff have relevant financial relationships to disclose:
Name Commercial Interest Conflict of Interest Activity role
John Rodgers Medtronic Honoraria, Speaker Faculty
Boston Scientific Honoraria, Consultant
“I have at present or have had within the last 24 months, a financial relationship with one or more
ineligible companies.”
iiCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing
Education. Any individuals in a position to control the content of a CME/CE activity, including faculty,
planners, reviewers, or others are required to disclose all financial relationships with ineligible entities
(commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of
the activity.
This activity is supported by an unrestricted grant from Medtronic.
This activity may include discussion of investigational or off-label uses of products or devices.
International Institute for Continuing Medical Education does not endorse or promote the use of any
product or device outside of its approved indications.
Artificial Intelligence (AI) Use Disclosure
In accordance with the standards and guidance set forth by the Accreditation Council for Continuing
Medical Education (ACCME), individuals in control of content are required to disclose the use of
artificial intelligence (AI) in the development of educational materials. This includes identification of the
specific AI tool(s) utilized and a description of how AI contributed to content creation.
iiCME maintains oversight of all educational content and conducts a thorough review process to ensure
that materials are evidence-based, fair-balanced, and free from commercial bias, consistent with ACCME
Standards for Integrity and Independence.
While AI may be used as a supportive tool in content development, it does not replace clinical expertise
or independent medical judgment. Learners are advised to critically evaluate all information presented
and apply their own professional judgment when incorporating knowledge into clinical practice.